Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 3/2015

01-03-2015 | Article

The effect of conventional mechanical periodontal treatment on red complex microorganisms and clinical parameters in Down syndrome periodontitis patients: a pilot study

Authors: M. H. Tanaka, T. O. Rodrigues, L. S. Finoti, S. R. L. Teixeira, M. P. A. Mayer, R. M. Scarel-Caminaga, E. M. A. Giro

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 3/2015

Login to get access

Abstract

Periodontal disease (PD) is induced by a complex microbiota, such as Porphyromonas gingivalis, Tannerella forsythia, and Treponema denticola (together called the red complex), which triggers intense inflammatory reaction. Down syndrome (DS) individuals demonstrate a high prevalence of PD compared with those who are otherwise chromosomally normal (euploids). This pilot study aimed to evaluate the effect of non-surgical periodontal treatment in DS chronic periodontitis patients on clinical and microbiological parameters. Patients with chronic periodontitis, 23 DS and 12 euploids (control group), were submitted to non-surgical mechanical periodontal treatment, followed by maintenance for 45 days. Clinical parameters after periodontal treatment were similar in diseased and healthy sites, independent of the genetic background. Diseased sites of DS and control patients harbored similar levels of P. gingivalis and T. forsythia at baseline, but significantly higher levels of T. denticola were found in DS patients. Increased levels of P. gingivalis at healthy sites were found in DS individuals. Non-surgical periodontal therapy decreased the levels of red complex microorganisms and improved the tested clinical parameters of diseased sites in both groups. However, the levels of red complex bacteria were higher in diseased sites of DS patients after the periodontal treatment. We conclude in this pilot study that, although the mechanical periodontal treatment seemed to be effective in DS subjects over a short-term period, the red complex bacteria levels did not decrease significantly in diseased sites, as occurred in controls. Therefore, for DS patients, it seems that the conventional non-surgical periodontal therapy should be improved by utilizing adjuvants to reduce the presence of periodontopathogens.
Literature
1.
4.
go back to reference Haffajee AD, Socransky SS (2000) Microbial etiological agents of destructive periodontal diseases. Periodontol 2000 5:78–111CrossRef Haffajee AD, Socransky SS (2000) Microbial etiological agents of destructive periodontal diseases. Periodontol 2000 5:78–111CrossRef
6.
go back to reference Finoti LS, Corbi SC, Anovazzi G, Teixeira SR, Capela MV, Tanaka MH, Kim YJ, Orrico SR, Cirelli JA, Mayer MP, Scarel-Caminaga RM (2013) Pathogen levels and clinical response to periodontal treatment in patients with Interleukin 8 haplotypes. Pathog Dis. doi:10.1111/2049-632X.12062 PubMed Finoti LS, Corbi SC, Anovazzi G, Teixeira SR, Capela MV, Tanaka MH, Kim YJ, Orrico SR, Cirelli JA, Mayer MP, Scarel-Caminaga RM (2013) Pathogen levels and clinical response to periodontal treatment in patients with Interleukin 8 haplotypes. Pathog Dis. doi:10.​1111/​2049-632X.​12062 PubMed
7.
go back to reference Kornman KS, Crane A, Wang HY, di Giovine FS, Newman MG, Pirk FW, Wilson TG Jr, Higginbottom FL, Duff GW (1997) The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol 24(1):72–77CrossRefPubMed Kornman KS, Crane A, Wang HY, di Giovine FS, Newman MG, Pirk FW, Wilson TG Jr, Higginbottom FL, Duff GW (1997) The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol 24(1):72–77CrossRefPubMed
8.
go back to reference Corbi SC, Finoti LS, Anovazzi G, Tanaka MH, Kim YJ, Secolin R, Marcaccini AM, Gerlach RF, Orrico SR, Cirelli JA, Scarel-Caminaga RM (2014) Clinical outcomes of periodontal therapy are not influenced by the ATC/TTC haplotype in the IL8 gene. J Periodontal Res 49(4):489–498. doi:10.1111/jre.12128 CrossRefPubMed Corbi SC, Finoti LS, Anovazzi G, Tanaka MH, Kim YJ, Secolin R, Marcaccini AM, Gerlach RF, Orrico SR, Cirelli JA, Scarel-Caminaga RM (2014) Clinical outcomes of periodontal therapy are not influenced by the ATC/TTC haplotype in the IL8 gene. J Periodontal Res 49(4):489–498. doi:10.​1111/​jre.​12128 CrossRefPubMed
9.
go back to reference Finoti LS, Anovazzi G, Pigossi SC, Corbi SC, Teixeira SR, Braido GV, Kim YJ, Orrico SR, Cirelli JA, Mayer MP, Scarel-Caminaga RM (2013) Periodontopathogens levels and clinical response to periodontal therapy in individuals with the interleukin-4 haplotype associated with susceptibility to chronic periodontitis. Eur J Clin Microbiol Infect Dis 32(12):1501–1509. doi:10.1007/s10096-013-1903-z CrossRefPubMed Finoti LS, Anovazzi G, Pigossi SC, Corbi SC, Teixeira SR, Braido GV, Kim YJ, Orrico SR, Cirelli JA, Mayer MP, Scarel-Caminaga RM (2013) Periodontopathogens levels and clinical response to periodontal therapy in individuals with the interleukin-4 haplotype associated with susceptibility to chronic periodontitis. Eur J Clin Microbiol Infect Dis 32(12):1501–1509. doi:10.​1007/​s10096-013-1903-z CrossRefPubMed
10.
go back to reference Cichon P, Crawford L, Grimm WD (1998) Early-onset periodontitis associated with Down’s syndrome—clinical interventional study. Ann Periodontol 3(1):370–380CrossRefPubMed Cichon P, Crawford L, Grimm WD (1998) Early-onset periodontitis associated with Down’s syndrome—clinical interventional study. Ann Periodontol 3(1):370–380CrossRefPubMed
11.
go back to reference Shapira L, Wilensky A, Kinane DF (2005) Effect of genetic variability on the inflammatory response to periodontal infection. J Clin Periodontol 32(Suppl 6):72–86CrossRefPubMed Shapira L, Wilensky A, Kinane DF (2005) Effect of genetic variability on the inflammatory response to periodontal infection. J Clin Periodontol 32(Suppl 6):72–86CrossRefPubMed
12.
go back to reference Cavalcante LB, Tanaka MH, Pires JR, Apponi LH, Aparecida Giro EM, Valentini SR, Palomari Spolidório DM, Capela MV, Rossa C Jr, Scarel-Caminaga RM (2012) Expression of the interleukin-10 signaling pathway genes in individuals with Down syndrome and periodontitis. J Periodontol 83(7):926–935. doi:10.1902/jop.2011.110056 CrossRefPubMed Cavalcante LB, Tanaka MH, Pires JR, Apponi LH, Aparecida Giro EM, Valentini SR, Palomari Spolidório DM, Capela MV, Rossa C Jr, Scarel-Caminaga RM (2012) Expression of the interleukin-10 signaling pathway genes in individuals with Down syndrome and periodontitis. J Periodontol 83(7):926–935. doi:10.​1902/​jop.​2011.​110056 CrossRefPubMed
13.
go back to reference Tanaka MH, Giro EM, Cavalcante LB, Pires JR, Apponi LH, Valentini SR, Spolidório DM, Capela MV, Rossa C Jr, Scarel-Caminaga RM (2012) Expression of interferon-γ, interferon-α and related genes in individuals with Down syndrome and periodontitis. Cytokine 60(3):875–881. doi:10.1016/j.cyto.2012.08.020 CrossRefPubMed Tanaka MH, Giro EM, Cavalcante LB, Pires JR, Apponi LH, Valentini SR, Spolidório DM, Capela MV, Rossa C Jr, Scarel-Caminaga RM (2012) Expression of interferon-γ, interferon-α and related genes in individuals with Down syndrome and periodontitis. Cytokine 60(3):875–881. doi:10.​1016/​j.​cyto.​2012.​08.​020 CrossRefPubMed
16.
go back to reference Yasui K, Shinozaki K, Nakazawa T, Agematsu K, Komiyama A (1999) Presenility of granulocytes in Down syndrome individuals. Am J Med Genet 84(5):406–412CrossRefPubMed Yasui K, Shinozaki K, Nakazawa T, Agematsu K, Komiyama A (1999) Presenility of granulocytes in Down syndrome individuals. Am J Med Genet 84(5):406–412CrossRefPubMed
17.
go back to reference Martinez-Martinez RE, Loyola-Rodriguez JP, Bonilla-Garro SE, Patiño-Marin N, Haubek D, Amano A, Poulsen K (2013) Characterization of periodontal biofilm in Down syndrome patients: a comparative study. J Clin Pediatr Dent 37(3):289–295PubMed Martinez-Martinez RE, Loyola-Rodriguez JP, Bonilla-Garro SE, Patiño-Marin N, Haubek D, Amano A, Poulsen K (2013) Characterization of periodontal biofilm in Down syndrome patients: a comparative study. J Clin Pediatr Dent 37(3):289–295PubMed
20.
go back to reference Sakellari D, Belibasakis G, Chadjipadelis T, Arapostathis K, Konstantinidis A (2001) Supragingival and subgingival microbiota of adult patients with Down’s syndrome. Changes after periodontal treatment. Oral Microbiol Immunol 16(6):376–382CrossRefPubMed Sakellari D, Belibasakis G, Chadjipadelis T, Arapostathis K, Konstantinidis A (2001) Supragingival and subgingival microbiota of adult patients with Down’s syndrome. Changes after periodontal treatment. Oral Microbiol Immunol 16(6):376–382CrossRefPubMed
21.
go back to reference Murakami J, Kato T, Kawai S, Akiyama S, Amano A, Morisaki I (2008) Cellular motility of Down syndrome gingival fibroblasts is susceptible to impairment by Porphyromonas gingivalis invasion. J Periodontol 79(4):721–727. doi:10.1902/jop.2008.070400 CrossRefPubMed Murakami J, Kato T, Kawai S, Akiyama S, Amano A, Morisaki I (2008) Cellular motility of Down syndrome gingival fibroblasts is susceptible to impairment by Porphyromonas gingivalis invasion. J Periodontol 79(4):721–727. doi:10.​1902/​jop.​2008.​070400 CrossRefPubMed
22.
go back to reference Yamazaki-Kubota T, Miyamoto M, Sano Y, Kusumoto M, Yonezu T, Sugita K, Okuda K, Yakushiji M, Ishihara K (2010) Analysis of matrix metalloproteinase (MMP-8 and MMP-2) activity in gingival crevicular fluid from children with Down’s syndrome. J Periodontal Res 45(2):170–176. doi:10.1111/j.1600-0765.2009.01214.x CrossRefPubMed Yamazaki-Kubota T, Miyamoto M, Sano Y, Kusumoto M, Yonezu T, Sugita K, Okuda K, Yakushiji M, Ishihara K (2010) Analysis of matrix metalloproteinase (MMP-8 and MMP-2) activity in gingival crevicular fluid from children with Down’s syndrome. J Periodontal Res 45(2):170–176. doi:10.​1111/​j.​1600-0765.​2009.​01214.​x CrossRefPubMed
24.
go back to reference Reuland-Bosma W, van der Reijden WA, van Winkelhoff AJ (2001) Absence of a specific subgingival microflora in adults with Down’s syndrome. J Clin Periodontol 28(11):1004–1009CrossRefPubMed Reuland-Bosma W, van der Reijden WA, van Winkelhoff AJ (2001) Absence of a specific subgingival microflora in adults with Down’s syndrome. J Clin Periodontol 28(11):1004–1009CrossRefPubMed
25.
go back to reference Petersen PE (2003) The World Oral Health Report 2003: continuous improvement of oral health in the 21st century—the approach of the WHO Global Oral Health Programme. Community Dent Oral Epidemiol 31(Suppl 1):3–23CrossRefPubMed Petersen PE (2003) The World Oral Health Report 2003: continuous improvement of oral health in the 21st century—the approach of the WHO Global Oral Health Programme. Community Dent Oral Epidemiol 31(Suppl 1):3–23CrossRefPubMed
27.
go back to reference Amano A, Nakagawa I, Kataoka K, Morisaki I, Hamada S (1999) Distribution of Porphyromonas gingivalis strains with fimA genotypes in periodontitis patients. J Clin Microbiol 37(5):1426–1430PubMedCentralPubMed Amano A, Nakagawa I, Kataoka K, Morisaki I, Hamada S (1999) Distribution of Porphyromonas gingivalis strains with fimA genotypes in periodontitis patients. J Clin Microbiol 37(5):1426–1430PubMedCentralPubMed
28.
go back to reference Mullally BH, Dace B, Shelburne CE, Wolff LF, Coulter WA (2000) Prevalence of periodontal pathogens in localized and generalized forms of early-onset periodontitis. J Periodontal Res 35(4):232–241CrossRefPubMed Mullally BH, Dace B, Shelburne CE, Wolff LF, Coulter WA (2000) Prevalence of periodontal pathogens in localized and generalized forms of early-onset periodontitis. J Periodontal Res 35(4):232–241CrossRefPubMed
29.
go back to reference Shelburne CE, Prabhu A, Gleason RM, Mullally BH, Coulter WA (2000) Quantitation of Bacteroides forsythus in subgingival plaque comparison of immunoassay and quantitative polymerase chain reaction. J Microbiol Methods 39(2):97–107CrossRefPubMed Shelburne CE, Prabhu A, Gleason RM, Mullally BH, Coulter WA (2000) Quantitation of Bacteroides forsythus in subgingival plaque comparison of immunoassay and quantitative polymerase chain reaction. J Microbiol Methods 39(2):97–107CrossRefPubMed
31.
go back to reference Meskin LH, Farsht EM, Anderson DL (1968) Prevalence of Bacteroides melaninogenicus in the gingival crevice area of institutionalized trisomy 21 and cerebral palsy patients and normal children. J Periodontol 39(6):326–328PubMed Meskin LH, Farsht EM, Anderson DL (1968) Prevalence of Bacteroides melaninogenicus in the gingival crevice area of institutionalized trisomy 21 and cerebral palsy patients and normal children. J Periodontol 39(6):326–328PubMed
32.
go back to reference Cutress TW, Brown RH, Guy EM (1970) Occurrence of some bacterial species in the dental plaque of trisomic 21 (mongoloid), other mentally retarded, and normal subjects. N Z Dent J 66(304):153–161PubMed Cutress TW, Brown RH, Guy EM (1970) Occurrence of some bacterial species in the dental plaque of trisomic 21 (mongoloid), other mentally retarded, and normal subjects. N Z Dent J 66(304):153–161PubMed
33.
go back to reference Reuland-Bosma W, van Dijk J (1986) Periodontal disease in Down’s syndrome: a review. J Clin Periodontol 13(1):64–73CrossRefPubMed Reuland-Bosma W, van Dijk J (1986) Periodontal disease in Down’s syndrome: a review. J Clin Periodontol 13(1):64–73CrossRefPubMed
36.
go back to reference Griffen AL, Becker MR, Lyons SR, Moeschberger ML, Leys EJ (1998) Prevalence of Porphyromonas gingivalis and periodontal health status. J Clin Microbiol 36(11):3239–3242PubMedCentralPubMed Griffen AL, Becker MR, Lyons SR, Moeschberger ML, Leys EJ (1998) Prevalence of Porphyromonas gingivalis and periodontal health status. J Clin Microbiol 36(11):3239–3242PubMedCentralPubMed
37.
go back to reference Sasaki Y, Sumi Y, Miyazaki Y, Hamachi T, Nakata M (2004) Periodontal management of an adolescent with Down’s syndrome—a case report. Int J Paediatr Dent 14(2):127–135CrossRefPubMed Sasaki Y, Sumi Y, Miyazaki Y, Hamachi T, Nakata M (2004) Periodontal management of an adolescent with Down’s syndrome—a case report. Int J Paediatr Dent 14(2):127–135CrossRefPubMed
39.
go back to reference Cugini MA, Haffajee AD, Smith C, Kent RL Jr, Socransky SS (2000) The effect of scaling and root planing on the clinical and microbiological parameters of periodontal diseases: 12-month results. J Clin Periodontol 27(1):30–36CrossRefPubMed Cugini MA, Haffajee AD, Smith C, Kent RL Jr, Socransky SS (2000) The effect of scaling and root planing on the clinical and microbiological parameters of periodontal diseases: 12-month results. J Clin Periodontol 27(1):30–36CrossRefPubMed
41.
go back to reference Muchová J, Sustrová M, Garaiová I, Liptáková A, Blazícek P, Kvasnicka P, Pueschel S, Duracková Z (2001) Influence of age on activities of antioxidant enzymes and lipid peroxidation products in erythrocytes and neutrophils of Down syndrome patients. Free Radic Biol Med 31(4):499–508CrossRefPubMed Muchová J, Sustrová M, Garaiová I, Liptáková A, Blazícek P, Kvasnicka P, Pueschel S, Duracková Z (2001) Influence of age on activities of antioxidant enzymes and lipid peroxidation products in erythrocytes and neutrophils of Down syndrome patients. Free Radic Biol Med 31(4):499–508CrossRefPubMed
42.
go back to reference Zaldivar-Chiapa RM, Arce-Mendoza AY, De La Rosa-Ramírez M, Caffesse RG, Solis-Soto JM (2005) Evaluation of surgical and non-surgical periodontal therapies, and immunological status, of young Down’s syndrome patients. J Periodontol 76(7):1061–1065. doi:10.1902/jop.2005.76.7.1061 CrossRefPubMed Zaldivar-Chiapa RM, Arce-Mendoza AY, De La Rosa-Ramírez M, Caffesse RG, Solis-Soto JM (2005) Evaluation of surgical and non-surgical periodontal therapies, and immunological status, of young Down’s syndrome patients. J Periodontol 76(7):1061–1065. doi:10.​1902/​jop.​2005.​76.​7.​1061 CrossRefPubMed
43.
go back to reference Sreedevi H, Munshi AK (1998) Neutrophil chemotaxis in Down syndrome and normal children to Actinobacillus actinomycetemcomitans. J Clin Pediatr Dent 22(2):141–146PubMed Sreedevi H, Munshi AK (1998) Neutrophil chemotaxis in Down syndrome and normal children to Actinobacillus actinomycetemcomitans. J Clin Pediatr Dent 22(2):141–146PubMed
44.
go back to reference Izumi Y, Sugiyama S, Shinozuka O, Yamazaki T, Ohyama T, Ishikawa I (1989) Defective neutrophil chemotaxis in Down’s syndrome patients and its relationship to periodontal destruction. J Periodontol 60(5):238–242CrossRefPubMed Izumi Y, Sugiyama S, Shinozuka O, Yamazaki T, Ohyama T, Ishikawa I (1989) Defective neutrophil chemotaxis in Down’s syndrome patients and its relationship to periodontal destruction. J Periodontol 60(5):238–242CrossRefPubMed
Metadata
Title
The effect of conventional mechanical periodontal treatment on red complex microorganisms and clinical parameters in Down syndrome periodontitis patients: a pilot study
Authors
M. H. Tanaka
T. O. Rodrigues
L. S. Finoti
S. R. L. Teixeira
M. P. A. Mayer
R. M. Scarel-Caminaga
E. M. A. Giro
Publication date
01-03-2015
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 3/2015
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-014-2268-7

Other articles of this Issue 3/2015

European Journal of Clinical Microbiology & Infectious Diseases 3/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine